In summary, our data indicated that RNF122 activated the JAK2/STAT3/c‐Myc axis to facilitate GBM cell proliferation and cell cycle and RNF122 activated JAK2/STAT3 signaling, which promoted c‐Myc protein expression and promoted GBM progression. The gene discussed is MYC; the disease is glioblastoma.